Evidence map›Paper›PMID 35939695›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Reciprocal interplay between OTULIN-LUBAC determines genotoxic and inflammatory NF-κB signal responses.

Mingqi Li, Ling Li, Sarah Asemota, David Kakhniashvili, Ramesh Narayanan, Xusheng Wang, Francesca-Fang Liao

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. The deubiquitinase OTULIN regulates tau expression and RNA metabolism in neurons.Genomic psychiatry : advancing science from genes to society · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mingqi LiDepartment of Pharmacology, Addiction Science, and Toxicology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163.ORCID 0000-0003-4595-285X
Ling LiDepartment of Biology, University of North Dakota, Grand Forks, ND 58202.ORCID 0000-0001-6295-2128
Sarah AsemotaDepartment of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103.
David KakhniashviliProteomics & Metabolomics Core Facility, Office of Research, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163.
Ramesh NarayananDepartment of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103.
Xusheng WangDepartment of Biology, University of North Dakota, Grand Forks, ND 58202.
Francesca-Fang LiaoDepartment of Pharmacology, Addiction Science, and Toxicology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163.ORCID 0000-0001-5144-3600
University of Tennessee Health Science Center · USUniversity of North Dakota · US

Funding

Racial Disparity in the Expression of Androgen Receptor Splice Variants (AR-SVs) in Prostate CancerR01CA229164 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Ramesh Narayanan · 2019 to 2026
$3.2M
Novel mechanistic link between metabolic changes and dementia - potential role of miRNAsRF1AG058467 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LIAO, FRANCESCA-FANG, YUE, JUNMING · 2018 to 2018
$2.7M
Validation of a novel tau clearance mechanism.RF1AG072703 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BHASKAR, KIRAN, LI, WEI · 2022 to 2022
$2.2M
Is HSF1 the key in mediating Hsp90 inhibitor effect in AD?R01AG049772 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LIAO, FRANCESCA-FANG · 2015 to 2019
$1.4M
Validation of a novel tau clearance mechanism.R01AG072703 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Kiran Bhaskar, WEI LI · 2025 to 2026
$1.4M
Blood-brain-barrier and white matter mechanisms underlying dementiaR01NS120327 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LIAO, FRANCESCA-FANG, ZHOU, FU-MING · 2024 to 2025
$1.0M
NCI NIH HHS R01 CA229164NIA NIH HHS R01 AG049772NIA NIH HHS R01 AG072703NIA NIH HHS RF1 AG058467NIA NIH HHS RF1 AG072703NINDS NIH HHS R01 NS120327
6 · The paper itself

Abstract

Targeting nuclear factor-kappa B (NF-κB) represents a highly viable strategy against chemoresistance in cancers as well as cell death. Ubiquitination, including linear ubiquitination mediated by the linear ubiquitin chain assembly complex (LUBAC), is emerging as a crucial mechanism of overactivated NF-κB signaling. Ovarian tumor family deubiquitinase OTULIN is the only linear linkage-specific deubiquitinase; however, the molecular mechanisms of how it counteracts LUBAC-mediated NF-κB activation have been largely unknown. Here, we identify Lys64/66 of OTULIN for linear ubiquitination facilitated in a LUBAC-dependent manner as a necessary event required for OTULIN-LUBAC interaction under unstressed conditions, which becomes deubiquitinated by OTULIN itself in response to genotoxic stress. Furthermore, this self-deubiquitination of OTULIN occurs intermolecularly, mediated by OTULIN dimerization, resulting in the subsequent dissociation of OTULIN from the LUBAC complex and NF-κB overactivation. Oxidative stress induces OTULIN dimerization via cysteine-mediated covalent disulfide bonds. Our study reveals that the status of the physical interaction between OTULIN and LUBAC is a crucial determining factor for the genotoxic NF-κB signaling, as measured by cell survival and proliferation, while OTULIN loss of function resulting from its dimerization and deubiquitination leads to a dissociation of OTULIN from the LUBAC complex. Of note, similar molecular mechanisms apply to the inflammatory NF-κB signaling in response to tumor necrosis factor α. Hence, a fuller understanding of the detailed molecular mechanisms underlying the disruption of the OTULIN-LUBAC interaction will be instrumental for developing future therapeutic strategies against cancer chemoresistance and necroptotic processes pertinent to numerous human diseases.

Indexed as

Deubiquitinating EnzymesDNA DamageEndopeptidasesInflammationNF-kappa BUbiquitin-Protein Ligase ComplexesDrug Resistance, NeoplasmHumansNecroptosisProtein MultimerizationSignal TransductionUbiquitinationDeubiquitinating EnzymesEndopeptidasesNF-kappa BOTULIN protein, humanUbiquitin-Protein Ligase ComplexesdeubiquitinasesinflammationLUBACNF-κBOTULIN

Identifiers

PMID35939695
PMCPMC9388121
OpenAlexW4290725267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.